Yin Yang 1 is a negative regulator of p53

被引:365
|
作者
Sui, GC
El Bachir, A
Shi, YJ
Brignone, C
Wall, NR
Yin, P
Donohoe, M
Luke, MP
Calvo, D
Grossman, SR
Shi, Y
机构
[1] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA
[2] Univ Massachusetts, Sch Med, Dept Canc Biol, Worcester, MA 01605 USA
[3] Univ Massachusetts, Sch Med, Dept Med, Worcester, MA 01605 USA
关键词
D O I
10.1016/j.cell.2004.06.004
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Yin Yang 1 (YY1) is a transcription factor that plays an essential role in development. However, the full spectrum of YY1's functions and mechanism of action remains unclear. We find that YY1 ablation results in p53 accumulation due to a reduction of p53 ubiquitination in vivo. Conversely, YY1 overexpression stimulates p53 ubiquitination and degradation. Significantly, recombinant YY1 is sufficient to induce Hdm2-mediated p53 polyubiquitination in vitro, suggesting that this function of YY1 is independent of its transcriptional activity. We identify direct physical interactions of YY1 with Hdm2 and p53 and show that the basis for YY1-regulating p53 ubiquitination is its ability to facilitate Hdm2-p53 interaction. Importantly, the tumor suppressor p14(ARF) compromises the Hdm2-YY1 interaction, which is important for YY1 regulation of p53. Taken together, these findings identify YY1 as a potential cofactor for Hdm2 in the regulation of p53 homeostasis and suggest a possible role for YY1 in tumorigenesis.
引用
收藏
页码:859 / 872
页数:14
相关论文
共 50 条
  • [41] The transcriptional regulator Yin Yang 1 activates the myelin PLP gene
    Berndt, JA
    Kim, JG
    Tosic, M
    Kim, C
    Hudson, LD
    JOURNAL OF NEUROCHEMISTRY, 2001, 77 (03) : 935 - 942
  • [42] Yin Yang 1 is a critical regulator of B-cell development
    Liu, Huifei
    Schmidt-Supprian, Marc
    Shi, Yujiang
    Hobeika, Elias
    Barteneva, Natasha
    Jumaa, Hassan
    Pelanda, Roberta
    Reth, Michael
    Skok, Jane
    Rajewsky, Klaus
    Shi, Yang
    GENES & DEVELOPMENT, 2007, 21 (10) : 1179 - 1189
  • [43] Polymorphisms of p53 and its negative regulator MDM2 in human melanoma
    Firoz, E. F.
    Warycha, M.
    Shapiro, R.
    Berman, R.
    Kamino, H.
    Darvishian, F.
    Rolnitzky, L.
    Goldberg, J.
    Osman, I.
    Polsky, D.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2008, 128 : S226 - S226
  • [44] Tumor suppressor p53 is a negative regulator in thyroid hormone receptor signaling pathways
    Bhat, MK
    Yu, CL
    Yap, N
    Zhan, QM
    Hayashi, Y
    Seth, P
    Cheng, SY
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (46) : 28989 - 28993
  • [45] The tumor suppressor p53 is a negative regulator of the carcinoma-associated transcription factor FOXQ1
    Pizzolato, Giulia
    Moparthi, Lavanya
    Pagella, Pierfrancesco
    Cantu, Claudio
    D'Arcy, Padraig
    Koch, Stefan
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2024, 300 (04)
  • [46] p53 as a Regulator of Lipid Metabolism in Cancer
    Parrales, Alejandro
    Iwakuma, Tomoo
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2016, 17 (12)
  • [47] Mutant p53 as a Regulator and Target of Autophagy
    Shi, Yong
    Norberg, Erik
    Vakifahmetoglu-Norberg, Helin
    FRONTIERS IN ONCOLOGY, 2021, 10
  • [48] ASPP - Apoptotic specific regulator of p53
    Liu, ZJ
    Lu, X
    Zhong, S
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2005, 1756 (01): : 77 - 80
  • [49] Mdmx as an essential regulator of p53 activity
    Marine, JC
    Jochemsen, AG
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2005, 331 (03) : 750 - 760
  • [50] Gfi1 as a regulator of p53 and a therapeutic target for ALL
    Khandanpour, Cyrus
    Moeroey, Tarik
    ONCOTARGET, 2013, 4 (03) : 374 - 375